Copyright
©2014 Baishideng Publishing Group Co.
World J Stem Cells. Apr 26, 2014; 6(2): 111-119
Published online Apr 26, 2014. doi: 10.4252/wjsc.v6.i2.111
Published online Apr 26, 2014. doi: 10.4252/wjsc.v6.i2.111
Table 2 Registered clinical trials on mesenchymal stem cells for retinal diseases
Identifier | Country | Status | Study | Phase of trial | Estimated number of patients | Estimated trial end | Disease |
NCT01531348 | Thailand | Enrolling by invitation | Feasibility and safety of adult human bone marrow-derived mesenchymal stem cells by intravitreal injection in patients with retinitis pigmentosa | Phase 1 | 10 | 2014 | Retinitis pigmentosa |
NCT01914913 | India | Not yet recruiting | Clinical study to evaluate safety and efficacy of stem cell therapy in retinitis pigmentosa | Phase 1/2 | 15 | 2015 | Retinitis pigmentosa |
NCT01920867 | United States | Recruiting | Stem cell ophthalmology treatment study | 300 | 2017 | Glaucoma, retinitis pigmentosa, age-related macular degeneration |
- Citation: Ng TK, Fortino VR, Pelaez D, Cheung HS. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells 2014; 6(2): 111-119
- URL: https://www.wjgnet.com/1948-0210/full/v6/i2/111.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v6.i2.111